# The National Health Service (Pharmaceutical Services) (Wales) Regulations 2020, Paragraph 8: Preliminary matters before providing ordered drugs or appliances

Extent: E+W

(1) If the person presenting the prescription form or repeatable prescription, or requesting the provision of drugs or appliances in accordance with a repeatable prescription, asks the NHS pharmacist to do so—
(a) the NHS pharmacist must give an estimate of the time when the drugs or appliances will be ready, and
(b) if they are not ready by then, the NHS pharmacist must give a revised estimate of the time when they will be ready (and so on).
(2) Before providing any drugs or appliances in accordance with a prescription form or a repeatable prescription—
(a) the NHS pharmacist must ask any person who makes a declaration that the person named on the prescription form or the repeatable prescription does not have to pay the charges specified in regulation 3(1) of the Charges Regulations (supply of drugs and appliances by chemists) by virtue of either—
(i) entitlement to exemption under regulation 8(1) (exemptions) of the Charges Regulations, or
(ii) entitlement to remission of such charges under regulation 5 of the Remission of Charges Regulations (remissible NHS charges),
to produce satisfactory evidence of such entitlement, unless the declaration is in respect of entitlement to exemption by regulation 8(1) of the Charges Regulations or in respect of entitlement to remission by virtue of sub-paragraphs (a) to (f) of regulation 5(2) of the Remission of Charges Regulations, and at the time of the declaration such evidence is already available to the NHS pharmacist, and
(b) if no satisfactory evidence, as required by paragraph (a), is produced to the NHS pharmacist, the NHS pharmacist must endorse the form on which the declaration is made to that effect.
(3) Sub-paragraph (2) applies to the provision of a drug or appliance in accordance with a SSP as it does to the provision of a drug or appliance in accordance with a prescription form or a repeatable prescription (or an associated batch issue), and for these purposes, the prescription for product reimbursement purposes, as mentioned in paragraph 6(4)(a), is treated as being the prescription in accordance with which the drug or appliance is provided (even though the supply is not in pursuance of that prescription).

---
Source: https://www.legislation.gov.uk/wsi/2020/1073/schedule/5/paragraph/8 (the official version)
Page: https://openlegislation.uk/national-health-service-pharmaceutical-services-wales-regulations-2020/schedule-5/paragraph-8
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.